Congenica Tries To Bring Clarity To Personalized Medicine For Rare Diseases
Medtech Insight spoke to David Atkins, the CEO of genomics company Congenica, to learn more about how its platform is being used in one of the largest genetics studies to date. The company expects the technology to eventually transform treatment of rare diseases.
You may also be interested in...
In this roundup feature focusing on developments in digital health, Medtech Insight highlights interviews with Medtronic, Abbott and Congenica, partnerships and launches, and AI and cybersecurity announcements from November.
Federated learning has taken another step forward thanks to new research that proves it is better at spotting brain tumors.
A selection of articles you might have missed from November 2022, during which In Vivo shone the spotlight on the Asia Pacific region.